{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Department of Oncology, Sahlgrenska University Hospital, Goteborg, Sweden",
    "Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden",
    "University of Gothenburg, Gothenburg, Västra Götaland, Sweden",
    "Department of Oncology, Institute of Clinical Sciences, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden",
    "Sahlgrenska University Hospital, Gothenburg, Västra Götaland, Sweden",
    "2CIPHE, Marseille, France",
    "1University of Gothenburg, Gothenburg, Sweden",
    "Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Västra Götaland, Sweden"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 11,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Max Levin"
    },
    {
      "affs": [
        1
      ],
      "name": "Anna Rudin"
    },
    {
      "affs": [
        2
      ],
      "name": "Anna-Carin Lundell"
    },
    {
      "affs": [
        3
      ],
      "name": "Sara Bjursten"
    },
    {
      "affs": [
        4
      ],
      "name": "Lars Ny"
    },
    {
      "affs": [
        5
      ],
      "name": "Hervé Luche"
    },
    {
      "affs": [
        6
      ],
      "name": "Sukanya Raghavan"
    },
    {
      "affs": [
        2
      ],
      "name": "Hifaa Al Remawi"
    },
    {
      "affs": [
        2
      ],
      "name": "Timothy Sundell"
    },
    {
      "affs": [
        2
      ],
      "name": "Maria Lindén"
    },
    {
      "affs": [
        7
      ],
      "name": "Maelle-Marine Monier"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/14akwrtm92ned.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0977",
  "fulltext_url": null,
  "id": "14akwrtm92ned",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0977",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225176051",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A1115.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/14akwrtm92ned.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T14:21:06Z",
      "native_id": "3a2be4a6a9114ee3ae84ca932f869e43",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0977"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "977 An ICOS–IFN-γ T-cell signature links CNS immune-related adverse events and immune-mediated hepatitis following dual CTLA-4/PD-1 blockade",
  "title_text": "977 An ICOS–IFN-γ T-cell signature links CNS immune-related adverse events and immune-mediated hepatitis following dual CTLA-4/PD-1 blockade",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T14:20:34Z",
  "url": "https://research.draconitic.com/paper/14akwrtm92ned",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}